GlassScriptPhysician profile
Naveen Subhas
NPI 1225067143
$33,134.37
in general payments reported to CMS, 2019-2025
7 companies · $867 in 2025
The $867 reported for 2025 was more than what 84% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,368 · 2022: $28.96 · 2023: $11K · 2024: $14K · 2025: $867.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $22K · Food and Beverage: $3,991.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $21,745.82 |
| Food and Beverage | $3,991.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $30,335.85 | 2019-2025 | Naeotom Alpha, Somatom Force, Magnetom Free.Max |
| Canon Healthcare USA, INC. | $1,245.06 | 2024 | |
| Ge Healthcare | $893.61 | 2023-2025 | |
| Agfa Healthcare Corporation | $229.93 | 2024 | |
| Amgen INC. | $196.55 | 2024 | Evenity |
| Bard Peripheral Vascular, INC. | $163.13 | 2023-2024 | Jamshidi, Trek |
| Canon Medical Systems USA, INC. | $70.24 | 2023 | Interventional Angiography System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naveen Subhas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.